# Rezolute, Inc.: Form D filings

Rezolute, Inc., a biotechnology company in Redwood City, CA, filed 16 Form D notices with the SEC between 2011 and 2020. The latest, on October 22, 2020, reports $41 million sold of a $57 million offering to 12 investors.

Find out what Rezolute, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Rezolute%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Rezolute%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Frezolute-inc-1509261)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Rezolute%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Rezolute%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Frezolute-inc-1509261)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 201 Redwood Shores Pkwy, Suite 315, Redwood City, CA, 94065
- Phone: (650) 206-4507
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1509261

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 22, 2020 | New notice | $56,990,020 | $41,000,000 | $15,990,020 | 12 | Oct 9, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000156761920018071/0001567619-20-018071-index.htm) |
| Apr 24, 2018 | Amendment | $6,000,000 | $4,800,000 | $1,200,000 | 34 | Jan 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036118019365/0001140361-18-019365-index.htm) |
| Feb 15, 2018 | New notice | $750,000 | $500,000 | $250,000 | 1 | Jan 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036118008721/0001140361-18-008721-index.htm) |
| Feb 7, 2018 | Amendment | $25,431,894 | $3,360,000 | $22,071,894 | 190 | Jan 31, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036118005503/0001140361-18-005503-index.htm) |
| Jan 11, 2018 | New notice | $10,137,868 | $137,868 | $10,000,000 | 1 | Dec 22, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036118001744/0001140361-18-001744-index.htm) |
| May 31, 2017 | New notice | $15,000,000 | $6,726,190 | $8,273,810 | 5 | Mar 6, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036117023032/0001140361-17-023032-index.htm) |
| Feb 14, 2017 | New notice | $25,431,894 | $3,360,000 | $22,071,894 | 190 | Jan 31, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036117007213/0001140361-17-007213-index.htm) |
| Jul 13, 2016 | New notice | $53,300,000 | $5,362,521 | $47,937,479 | 60 | Jun 24, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036116072394/0001140361-16-072394-index.htm) |
| Mar 22, 2016 | Amendment | $16,709,995 | $4,347,615 | $12,362,380 | 11 | Dec 10, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036116058644/0001140361-16-058644-index.htm) |
| Dec 21, 2015 | New notice | $15,150,008 | $2,000,115 | $13,149,893 | 6 | Dec 10, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036115045238/0001140361-15-045238-index.htm) |
| Apr 14, 2015 | New notice | $4,702,703 | $1,984,012 | $2,718,691 | 14 | Mar 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036115015335/0001140361-15-015335-index.htm) |
| Jan 26, 2015 | New notice | $35,270,270 | $6,925,580 | $28,344,690 | 73 | Nov 28, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036115002749/0001140361-15-002749-index.htm) |
| Apr 28, 2014 | Amendment | $26,250,000 | $8,931,433 | $17,318,567 | 113 | Mar 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036114017665/0001140361-14-017665-index.htm) |
| Apr 14, 2014 | New notice | $26,250,000 | $7,296,453 | $18,953,547 | 82 | Mar 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036114016656/0001140361-14-016656-index.htm) |
| Jan 14, 2014 | New notice | $3,500,000 | $1,420,000 | $2,080,000 | 7 | Dec 23, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114036114002158/0001140361-14-002158-index.htm) |
| May 17, 2011 | New notice | $6,000 | $6,000 | $0 | 6 | Oct 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1509261/000114420411030339/0001144204-11-030339-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Keith Charles Vendola | Executive Officer |  |
| Young-Jin Charles Kim | Director |  |
| Jung-Hee Charles Lim | Director |  |
| Philippe Charles Fauchet | Director |  |
| Sankaram Charles Mantripragada | Executive Officer |  |
| Nevan Charles Elam | Executive Officer, Director |  |
| Gil Charles Labrucherie | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of Oct 19, 2020](https://specstream.ai/data/form-d/week/2020-10-19) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Rezolute, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).